[1]
A. Ostor, “Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 3-year Analysis of the KEEPsAKE 1 and 2 Trials”, J of Skin, vol. 7, no. 6, p. s249, Nov. 2023.